We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Committees and advisory bodies (305)
- Scheduling (national classification system) (160)
- Advertising (25)
- Safety monitoring and information (23)
- COVID-19 (11)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Clinical trials (4)
- Compliance and enforcement (4)
- Shortages and supply disruptions (3)
- Legislation (2)
- Breast implant hub (1)
- Cosmetics (1)
- Import and export (1)
- Manufacturing (1)
- Prescription opioids hub (1)
Search
574 result(s) found, displaying 501 to 525
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS
-
Meeting statementsTherapeutic Goods Committee, 20 June 2014, meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 16 meeting statement
-
Corporate reportsTGA approach to disclosure of commercially confidential information (CCI)
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Meeting statementsAdvisory Committee on Non-prescription Medicines, 6 March 2014, meeting statement
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the fourth time on 4 February 2014
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 15 meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 295 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 294 meeting statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 3 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 293 meeting statement
-
Meeting statementsThe Australian Therapeutic Goods Advisory Council met for the third time on 6 August 2013
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 14 meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 292 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, ACMS and the joint ACCS-ACMS
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 291 meeting statement
-
Meeting statementsAdvisory Committee on Biologicals, Meeting 2 statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 290 meeting statement
-
Meeting statementsThe TGA asked the ACMD to consider acceptable levels of sensitivity and specificity for Hepatitis C (HCV) and Human Immunodeficiency Virus (HIV) PoCTs
-
Meeting statementsAdvisory Committee on Non-prescription Medicines, 7 March 2013, meeting statement
-
Meeting statementsAdvisory Committee on Prescription Medicines Meeting 289 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACCS, the joint ACCS and ACMS and ACMS
-
Meeting statementsAustralian Therapeutic Goods Advisory Council met for the second time on 5 February 2013